You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

LIDOCAINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for lidocaine and what is the scope of freedom to operate?

Lidocaine is the generic ingredient in forty-five branded drugs marketed by Astrazeneca, Noven, Carlisle, Alembic, Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Belmora Llc, Cosette, Dr Reddys, Encube, Fougera Pharms Inc, Geneyork Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Quagen, Rising, Septodont Inc, Strides Pharma, Taro, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Amneal, Ibsa, Mylan Technologies, Nal Pharm, Noven Pharms Inc, Teikoku Pharma Usa, Scilex Pharms, Thea Pharma, Abbott, Abraxis Pharm, Afaxys, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Mankind Pharma, Miles, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Hikma, Pharmaton, Meridian Medcl Techn, Dentsply Pharm, Bionpharma, Sagent Pharms Inc, Sentiss, Watson Labs Inc, Rubicon, Wockhardt Bio Ag, Actavis Mid Atlantic, Chartwell Molecular, Pai Holdings Pharm, Kendall Il, Lannett Co Inc, Novitium Pharma, Paco, The J Molner, Powder Pharms, Pfizer, Teva Branded Pharm, Fougera Pharms, Padagis Us, Rhodes Pharms, Crescita Therap, and Galen Specialty, and is included in one hundred and sixty NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Lidocaine has thirty-seven patent family members in eighteen countries.

There are twenty-nine drug master file entries for lidocaine. Forty-four suppliers are listed for this compound.

Drug Prices for LIDOCAINE

See drug prices for LIDOCAINE

Drug Sales Revenue Trends for LIDOCAINE

See drug sales revenues for LIDOCAINE

Recent Clinical Trials for LIDOCAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sichuan Cancer Hospital and Research InstituteN/A
Jessyka LighthallPhase 3
Sawanpracharak hospitalN/A

See all LIDOCAINE clinical trials

Pharmacology for LIDOCAINE
Medical Subject Heading (MeSH) Categories for LIDOCAINE
Paragraph IV (Patent) Challenges for LIDOCAINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZTLIDO Topical Patch lidocaine 1.80% 207962 1 2022-03-17
LIDODERM Topical Patch lidocaine 5% 020612 1 2009-11-13

US Patents and Regulatory Information for LIDOCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088330-001 May 17, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088331-001 May 17, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088586-003 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mankind Pharma LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 217693-002 Jul 11, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Intl Medication LARYNG-O-JET KIT lidocaine hydrochloride SOLUTION;TOPICAL 086364-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 084625-002 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LIDOCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LIDOCAINE

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2012153396 ⤷  Sign Up
Spain 2743524 ⤷  Sign Up
Brazil 112013028802 curativo adesivo não aquoso ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2013046335 ⤷  Sign Up
Taiwan 201318652 Non-aqueous patch ⤷  Sign Up
Japan WO2013046335 非水性貼付剤 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.